0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rheumatoid Arthritis Medicine Market Research Report 2023
Published Date: November 2023
|
Report Code: QYRE-Auto-27I11141
Home | Market Reports | Health| Health Conditions| Arthritis
Global Rheumatoid Arthritis Medicine Market Research Report 2022
BUY CHAPTERS

Global Rheumatoid Arthritis Medicine Market Research Report 2023

Code: QYRE-Auto-27I11141
Report
November 2023
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Rheumatoid Arthritis Medicine Market Size

According to new survey, global Rheumatoid Arthritis Medicine market is projected to reach US$ 485.7 million in 2029, increasing from US$ 358 million in 2022, with the CAGR of 4.5% during the period of 2023 to 2029.

Rheumatoid Arthritis Medicine Market

Rheumatoid Arthritis Medicine Market

Rheumatoid Arthritis is an autoimmune disease that causes pain, swelling, and stiffness in the joints, and may cause severe joint damage, loss of function, and disability. The disease may last from months to a lifetime, and symptoms may improve and worsen over time.
Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Rheumatoid Arthritis Medicine market research.
Key manufacturers engaged in the Rheumatoid Arthritis Medicine industry include AbbVie Inc, Hoffman-La Roche AG, Amgen Inc, Pfizer Inc, Bristol-Myers Squibb Co, Johnson & Johnson, UCB Biosciences Inc, Mitsubishi Tanabe Pharma Corp and Biogen Inc, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Rheumatoid Arthritis Medicine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Rheumatoid Arthritis Medicine market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Rheumatoid Arthritis Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Rheumatoid Arthritis Medicine Market Report

Report Metric Details
Report Name Rheumatoid Arthritis Medicine Market
Accounted market size in 2022 US$ 358 million
Forecasted market size in 2029 US$ 485.7 million
CAGR 4.5%
Base Year 2022
Forecasted years 2023 - 2029
Segment by Type
  • Prescription Drugs
  • OTC Drugs
Segment by Application
  • Hospital
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie Inc, Hoffman-La Roche AG, Amgen Inc, Pfizer Inc, Bristol-Myers Squibb Co, Johnson & Johnson, UCB Biosciences Inc, Mitsubishi Tanabe Pharma Corp, Biogen Inc, Merck & Co, Haute Autorité de Santé
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Rheumatoid Arthritis Medicine Market growing?

Ans: The Rheumatoid Arthritis Medicine Market witnessing a CAGR of 4.5% during the forecast period 2023-2029.

What is the Rheumatoid Arthritis Medicine Market size in 2029?

Ans: The Rheumatoid Arthritis Medicine Market size in 2029 will be US$ 485.7 million.

Who are the main players in the Rheumatoid Arthritis Medicine Market report?

Ans: The main players in the Rheumatoid Arthritis Medicine Market are AbbVie Inc, Hoffman-La Roche AG, Amgen Inc, Pfizer Inc, Bristol-Myers Squibb Co, Johnson & Johnson, UCB Biosciences Inc, Mitsubishi Tanabe Pharma Corp, Biogen Inc, Merck & Co, Haute Autorité de Santé

What are the Application segmentation covered in the Rheumatoid Arthritis Medicine Market report?

Ans: The Applications covered in the Rheumatoid Arthritis Medicine Market report are Hospital, Clinics, Others

What are the Type segmentation covered in the Rheumatoid Arthritis Medicine Market report?

Ans: The Types covered in the Rheumatoid Arthritis Medicine Market report are Prescription Drugs, OTC Drugs

1 Rheumatoid Arthritis Medicine Market Overview
1.1 Product Overview and Scope of Rheumatoid Arthritis Medicine
1.2 Rheumatoid Arthritis Medicine Segment by Type
1.2.1 Global Rheumatoid Arthritis Medicine Market Value Comparison by Type (2023-2029)
1.2.2 Prescription Drugs
1.2.3 OTC Drugs
1.3 Rheumatoid Arthritis Medicine Segment by Application
1.3.1 Global Rheumatoid Arthritis Medicine Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Global Rheumatoid Arthritis Medicine Market Size Estimates and Forecasts
1.4.1 Global Rheumatoid Arthritis Medicine Revenue 2018-2029
1.4.2 Global Rheumatoid Arthritis Medicine Sales 2018-2029
1.4.3 Global Rheumatoid Arthritis Medicine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Rheumatoid Arthritis Medicine Market Competition by Manufacturers
2.1 Global Rheumatoid Arthritis Medicine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Rheumatoid Arthritis Medicine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Rheumatoid Arthritis Medicine Average Price by Manufacturers (2018-2023)
2.4 Global Rheumatoid Arthritis Medicine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Rheumatoid Arthritis Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rheumatoid Arthritis Medicine, Product Type & Application
2.7 Rheumatoid Arthritis Medicine Market Competitive Situation and Trends
2.7.1 Rheumatoid Arthritis Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rheumatoid Arthritis Medicine Players Market Share by Revenue
2.7.3 Global Rheumatoid Arthritis Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rheumatoid Arthritis Medicine Retrospective Market Scenario by Region
3.1 Global Rheumatoid Arthritis Medicine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Rheumatoid Arthritis Medicine Global Rheumatoid Arthritis Medicine Sales by Region: 2018-2029
3.2.1 Global Rheumatoid Arthritis Medicine Sales by Region: 2018-2023
3.2.2 Global Rheumatoid Arthritis Medicine Sales by Region: 2024-2029
3.3 Global Rheumatoid Arthritis Medicine Global Rheumatoid Arthritis Medicine Revenue by Region: 2018-2029
3.3.1 Global Rheumatoid Arthritis Medicine Revenue by Region: 2018-2023
3.3.2 Global Rheumatoid Arthritis Medicine Revenue by Region: 2024-2029
3.4 North America Rheumatoid Arthritis Medicine Market Facts & Figures by Country
3.4.1 North America Rheumatoid Arthritis Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Rheumatoid Arthritis Medicine Sales by Country (2018-2029)
3.4.3 North America Rheumatoid Arthritis Medicine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rheumatoid Arthritis Medicine Market Facts & Figures by Country
3.5.1 Europe Rheumatoid Arthritis Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Rheumatoid Arthritis Medicine Sales by Country (2018-2029)
3.5.3 Europe Rheumatoid Arthritis Medicine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rheumatoid Arthritis Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific Rheumatoid Arthritis Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Rheumatoid Arthritis Medicine Sales by Country (2018-2029)
3.6.3 Asia Pacific Rheumatoid Arthritis Medicine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Rheumatoid Arthritis Medicine Market Facts & Figures by Country
3.7.1 Latin America Rheumatoid Arthritis Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Rheumatoid Arthritis Medicine Sales by Country (2018-2029)
3.7.3 Latin America Rheumatoid Arthritis Medicine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rheumatoid Arthritis Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Rheumatoid Arthritis Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Rheumatoid Arthritis Medicine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Rheumatoid Arthritis Medicine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rheumatoid Arthritis Medicine Sales by Type (2018-2029)
4.1.1 Global Rheumatoid Arthritis Medicine Sales by Type (2018-2023)
4.1.2 Global Rheumatoid Arthritis Medicine Sales by Type (2024-2029)
4.1.3 Global Rheumatoid Arthritis Medicine Sales Market Share by Type (2018-2029)
4.2 Global Rheumatoid Arthritis Medicine Revenue by Type (2018-2029)
4.2.1 Global Rheumatoid Arthritis Medicine Revenue by Type (2018-2023)
4.2.2 Global Rheumatoid Arthritis Medicine Revenue by Type (2024-2029)
4.2.3 Global Rheumatoid Arthritis Medicine Revenue Market Share by Type (2018-2029)
4.3 Global Rheumatoid Arthritis Medicine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Rheumatoid Arthritis Medicine Sales by Application (2018-2029)
5.1.1 Global Rheumatoid Arthritis Medicine Sales by Application (2018-2023)
5.1.2 Global Rheumatoid Arthritis Medicine Sales by Application (2024-2029)
5.1.3 Global Rheumatoid Arthritis Medicine Sales Market Share by Application (2018-2029)
5.2 Global Rheumatoid Arthritis Medicine Revenue by Application (2018-2029)
5.2.1 Global Rheumatoid Arthritis Medicine Revenue by Application (2018-2023)
5.2.2 Global Rheumatoid Arthritis Medicine Revenue by Application (2024-2029)
5.2.3 Global Rheumatoid Arthritis Medicine Revenue Market Share by Application (2018-2029)
5.3 Global Rheumatoid Arthritis Medicine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AbbVie Inc
6.1.1 AbbVie Inc Corporation Information
6.1.2 AbbVie Inc Description and Business Overview
6.1.3 AbbVie Inc Rheumatoid Arthritis Medicine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AbbVie Inc Rheumatoid Arthritis Medicine Product Portfolio
6.1.5 AbbVie Inc Recent Developments/Updates
6.2 Hoffman-La Roche AG
6.2.1 Hoffman-La Roche AG Corporation Information
6.2.2 Hoffman-La Roche AG Description and Business Overview
6.2.3 Hoffman-La Roche AG Rheumatoid Arthritis Medicine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Hoffman-La Roche AG Rheumatoid Arthritis Medicine Product Portfolio
6.2.5 Hoffman-La Roche AG Recent Developments/Updates
6.3 Amgen Inc
6.3.1 Amgen Inc Corporation Information
6.3.2 Amgen Inc Description and Business Overview
6.3.3 Amgen Inc Rheumatoid Arthritis Medicine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Amgen Inc Rheumatoid Arthritis Medicine Product Portfolio
6.3.5 Amgen Inc Recent Developments/Updates
6.4 Pfizer Inc
6.4.1 Pfizer Inc Corporation Information
6.4.2 Pfizer Inc Description and Business Overview
6.4.3 Pfizer Inc Rheumatoid Arthritis Medicine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Inc Rheumatoid Arthritis Medicine Product Portfolio
6.4.5 Pfizer Inc Recent Developments/Updates
6.5 Bristol-Myers Squibb Co
6.5.1 Bristol-Myers Squibb Co Corporation Information
6.5.2 Bristol-Myers Squibb Co Description and Business Overview
6.5.3 Bristol-Myers Squibb Co Rheumatoid Arthritis Medicine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bristol-Myers Squibb Co Rheumatoid Arthritis Medicine Product Portfolio
6.5.5 Bristol-Myers Squibb Co Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Rheumatoid Arthritis Medicine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Johnson & Johnson Rheumatoid Arthritis Medicine Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 UCB Biosciences Inc
6.6.1 UCB Biosciences Inc Corporation Information
6.6.2 UCB Biosciences Inc Description and Business Overview
6.6.3 UCB Biosciences Inc Rheumatoid Arthritis Medicine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 UCB Biosciences Inc Rheumatoid Arthritis Medicine Product Portfolio
6.7.5 UCB Biosciences Inc Recent Developments/Updates
6.8 Mitsubishi Tanabe Pharma Corp
6.8.1 Mitsubishi Tanabe Pharma Corp Corporation Information
6.8.2 Mitsubishi Tanabe Pharma Corp Description and Business Overview
6.8.3 Mitsubishi Tanabe Pharma Corp Rheumatoid Arthritis Medicine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Mitsubishi Tanabe Pharma Corp Rheumatoid Arthritis Medicine Product Portfolio
6.8.5 Mitsubishi Tanabe Pharma Corp Recent Developments/Updates
6.9 Biogen Inc
6.9.1 Biogen Inc Corporation Information
6.9.2 Biogen Inc Description and Business Overview
6.9.3 Biogen Inc Rheumatoid Arthritis Medicine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Biogen Inc Rheumatoid Arthritis Medicine Product Portfolio
6.9.5 Biogen Inc Recent Developments/Updates
6.10 Merck & Co
6.10.1 Merck & Co Corporation Information
6.10.2 Merck & Co Description and Business Overview
6.10.3 Merck & Co Rheumatoid Arthritis Medicine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Merck & Co Rheumatoid Arthritis Medicine Product Portfolio
6.10.5 Merck & Co Recent Developments/Updates
6.11 Haute Autorité de Santé
6.11.1 Haute Autorité de Santé Corporation Information
6.11.2 Haute Autorité de Santé Rheumatoid Arthritis Medicine Description and Business Overview
6.11.3 Haute Autorité de Santé Rheumatoid Arthritis Medicine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Haute Autorité de Santé Rheumatoid Arthritis Medicine Product Portfolio
6.11.5 Haute Autorité de Santé Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rheumatoid Arthritis Medicine Industry Chain Analysis
7.2 Rheumatoid Arthritis Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rheumatoid Arthritis Medicine Production Mode & Process
7.4 Rheumatoid Arthritis Medicine Sales and Marketing
7.4.1 Rheumatoid Arthritis Medicine Sales Channels
7.4.2 Rheumatoid Arthritis Medicine Distributors
7.5 Rheumatoid Arthritis Medicine Customers
8 Rheumatoid Arthritis Medicine Market Dynamics
8.1 Rheumatoid Arthritis Medicine Industry Trends
8.2 Rheumatoid Arthritis Medicine Market Drivers
8.3 Rheumatoid Arthritis Medicine Market Challenges
8.4 Rheumatoid Arthritis Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Rheumatoid Arthritis Medicine Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Rheumatoid Arthritis Medicine Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Rheumatoid Arthritis Medicine Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Rheumatoid Arthritis Medicine Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Rheumatoid Arthritis Medicine Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Rheumatoid Arthritis Medicine Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Rheumatoid Arthritis Medicine Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Rheumatoid Arthritis Medicine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Rheumatoid Arthritis Medicine, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Rheumatoid Arthritis Medicine, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Rheumatoid Arthritis Medicine, Product Type & Application
    Table 12. Global Key Manufacturers of Rheumatoid Arthritis Medicine, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Rheumatoid Arthritis Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Medicine as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Rheumatoid Arthritis Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Rheumatoid Arthritis Medicine Sales by Region (2018-2023) & (K Units)
    Table 18. Global Rheumatoid Arthritis Medicine Sales Market Share by Region (2018-2023)
    Table 19. Global Rheumatoid Arthritis Medicine Sales by Region (2024-2029) & (K Units)
    Table 20. Global Rheumatoid Arthritis Medicine Sales Market Share by Region (2024-2029)
    Table 21. Global Rheumatoid Arthritis Medicine Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Rheumatoid Arthritis Medicine Revenue Market Share by Region (2018-2023)
    Table 23. Global Rheumatoid Arthritis Medicine Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Rheumatoid Arthritis Medicine Revenue Market Share by Region (2024-2029)
    Table 25. North America Rheumatoid Arthritis Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Rheumatoid Arthritis Medicine Sales by Country (2018-2023) & (K Units)
    Table 27. North America Rheumatoid Arthritis Medicine Sales by Country (2024-2029) & (K Units)
    Table 28. North America Rheumatoid Arthritis Medicine Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Rheumatoid Arthritis Medicine Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Rheumatoid Arthritis Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Rheumatoid Arthritis Medicine Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Rheumatoid Arthritis Medicine Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Rheumatoid Arthritis Medicine Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Rheumatoid Arthritis Medicine Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Rheumatoid Arthritis Medicine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Rheumatoid Arthritis Medicine Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Rheumatoid Arthritis Medicine Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Rheumatoid Arthritis Medicine Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Rheumatoid Arthritis Medicine Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Rheumatoid Arthritis Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Rheumatoid Arthritis Medicine Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Rheumatoid Arthritis Medicine Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Rheumatoid Arthritis Medicine Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Rheumatoid Arthritis Medicine Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Rheumatoid Arthritis Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Rheumatoid Arthritis Medicine Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Rheumatoid Arthritis Medicine Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Rheumatoid Arthritis Medicine Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Rheumatoid Arthritis Medicine Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Rheumatoid Arthritis Medicine Sales (K Units) by Type (2018-2023)
    Table 51. Global Rheumatoid Arthritis Medicine Sales (K Units) by Type (2024-2029)
    Table 52. Global Rheumatoid Arthritis Medicine Sales Market Share by Type (2018-2023)
    Table 53. Global Rheumatoid Arthritis Medicine Sales Market Share by Type (2024-2029)
    Table 54. Global Rheumatoid Arthritis Medicine Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Rheumatoid Arthritis Medicine Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Rheumatoid Arthritis Medicine Revenue Market Share by Type (2018-2023)
    Table 57. Global Rheumatoid Arthritis Medicine Revenue Market Share by Type (2024-2029)
    Table 58. Global Rheumatoid Arthritis Medicine Price (US$/Unit) by Type (2018-2023)
    Table 59. Global Rheumatoid Arthritis Medicine Price (US$/Unit) by Type (2024-2029)
    Table 60. Global Rheumatoid Arthritis Medicine Sales (K Units) by Application (2018-2023)
    Table 61. Global Rheumatoid Arthritis Medicine Sales (K Units) by Application (2024-2029)
    Table 62. Global Rheumatoid Arthritis Medicine Sales Market Share by Application (2018-2023)
    Table 63. Global Rheumatoid Arthritis Medicine Sales Market Share by Application (2024-2029)
    Table 64. Global Rheumatoid Arthritis Medicine Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Rheumatoid Arthritis Medicine Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Rheumatoid Arthritis Medicine Revenue Market Share by Application (2018-2023)
    Table 67. Global Rheumatoid Arthritis Medicine Revenue Market Share by Application (2024-2029)
    Table 68. Global Rheumatoid Arthritis Medicine Price (US$/Unit) by Application (2018-2023)
    Table 69. Global Rheumatoid Arthritis Medicine Price (US$/Unit) by Application (2024-2029)
    Table 70. AbbVie Inc Corporation Information
    Table 71. AbbVie Inc Description and Business Overview
    Table 72. AbbVie Inc Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 73. AbbVie Inc Rheumatoid Arthritis Medicine Product
    Table 74. AbbVie Inc Recent Developments/Updates
    Table 75. Hoffman-La Roche AG Corporation Information
    Table 76. Hoffman-La Roche AG Description and Business Overview
    Table 77. Hoffman-La Roche AG Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 78. Hoffman-La Roche AG Rheumatoid Arthritis Medicine Product
    Table 79. Hoffman-La Roche AG Recent Developments/Updates
    Table 80. Amgen Inc Corporation Information
    Table 81. Amgen Inc Description and Business Overview
    Table 82. Amgen Inc Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 83. Amgen Inc Rheumatoid Arthritis Medicine Product
    Table 84. Amgen Inc Recent Developments/Updates
    Table 85. Pfizer Inc Corporation Information
    Table 86. Pfizer Inc Description and Business Overview
    Table 87. Pfizer Inc Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 88. Pfizer Inc Rheumatoid Arthritis Medicine Product
    Table 89. Pfizer Inc Recent Developments/Updates
    Table 90. Bristol-Myers Squibb Co Corporation Information
    Table 91. Bristol-Myers Squibb Co Description and Business Overview
    Table 92. Bristol-Myers Squibb Co Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 93. Bristol-Myers Squibb Co Rheumatoid Arthritis Medicine Product
    Table 94. Bristol-Myers Squibb Co Recent Developments/Updates
    Table 95. Johnson & Johnson Corporation Information
    Table 96. Johnson & Johnson Description and Business Overview
    Table 97. Johnson & Johnson Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 98. Johnson & Johnson Rheumatoid Arthritis Medicine Product
    Table 99. Johnson & Johnson Recent Developments/Updates
    Table 100. UCB Biosciences Inc Corporation Information
    Table 101. UCB Biosciences Inc Description and Business Overview
    Table 102. UCB Biosciences Inc Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 103. UCB Biosciences Inc Rheumatoid Arthritis Medicine Product
    Table 104. UCB Biosciences Inc Recent Developments/Updates
    Table 105. Mitsubishi Tanabe Pharma Corp Corporation Information
    Table 106. Mitsubishi Tanabe Pharma Corp Description and Business Overview
    Table 107. Mitsubishi Tanabe Pharma Corp Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 108. Mitsubishi Tanabe Pharma Corp Rheumatoid Arthritis Medicine Product
    Table 109. Mitsubishi Tanabe Pharma Corp Recent Developments/Updates
    Table 110. Biogen Inc Corporation Information
    Table 111. Biogen Inc Description and Business Overview
    Table 112. Biogen Inc Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 113. Biogen Inc Rheumatoid Arthritis Medicine Product
    Table 114. Biogen Inc Recent Developments/Updates
    Table 115. Merck & Co Corporation Information
    Table 116. Merck & Co Description and Business Overview
    Table 117. Merck & Co Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 118. Merck & Co Rheumatoid Arthritis Medicine Product
    Table 119. Merck & Co Recent Developments/Updates
    Table 120. Haute Autorité de Santé Corporation Information
    Table 121. Haute Autorité de Santé Description and Business Overview
    Table 122. Haute Autorité de Santé Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 123. Haute Autorité de Santé Rheumatoid Arthritis Medicine Product
    Table 124. Haute Autorité de Santé Recent Developments/Updates
    Table 125. Key Raw Materials Lists
    Table 126. Raw Materials Key Suppliers Lists
    Table 127. Rheumatoid Arthritis Medicine Distributors List
    Table 128. Rheumatoid Arthritis Medicine Customers List
    Table 129. Rheumatoid Arthritis Medicine Market Trends
    Table 130. Rheumatoid Arthritis Medicine Market Drivers
    Table 131. Rheumatoid Arthritis Medicine Market Challenges
    Table 132. Rheumatoid Arthritis Medicine Market Restraints
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Rheumatoid Arthritis Medicine
    Figure 2. Global Rheumatoid Arthritis Medicine Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Rheumatoid Arthritis Medicine Market Share by Type in 2022 & 2029
    Figure 4. Prescription Drugs Product Picture
    Figure 5. OTC Drugs Product Picture
    Figure 6. Global Rheumatoid Arthritis Medicine Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Rheumatoid Arthritis Medicine Market Share by Application in 2022 & 2029
    Figure 8. Hospital
    Figure 9. Clinics
    Figure 10. Others
    Figure 11. Global Rheumatoid Arthritis Medicine Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 12. Global Rheumatoid Arthritis Medicine Market Size (2018-2029) & (US$ Million)
    Figure 13. Global Rheumatoid Arthritis Medicine Sales (2018-2029) & (K Units)
    Figure 14. Global Rheumatoid Arthritis Medicine Average Price (US$/Unit) & (2018-2029)
    Figure 15. Rheumatoid Arthritis Medicine Report Years Considered
    Figure 16. Rheumatoid Arthritis Medicine Sales Share by Manufacturers in 2022
    Figure 17. Global Rheumatoid Arthritis Medicine Revenue Share by Manufacturers in 2022
    Figure 18. The Global 5 and 10 Largest Rheumatoid Arthritis Medicine Players: Market Share by Revenue in 2022
    Figure 19. Rheumatoid Arthritis Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 20. Global Rheumatoid Arthritis Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 21. North America Rheumatoid Arthritis Medicine Sales Market Share by Country (2018-2029)
    Figure 22. North America Rheumatoid Arthritis Medicine Revenue Market Share by Country (2018-2029)
    Figure 23. United States Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 24. Canada Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 25. Europe Rheumatoid Arthritis Medicine Sales Market Share by Country (2018-2029)
    Figure 26. Europe Rheumatoid Arthritis Medicine Revenue Market Share by Country (2018-2029)
    Figure 27. Germany Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 28. France Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. U.K. Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. Italy Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. Russia Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Asia Pacific Rheumatoid Arthritis Medicine Sales Market Share by Region (2018-2029)
    Figure 33. Asia Pacific Rheumatoid Arthritis Medicine Revenue Market Share by Region (2018-2029)
    Figure 34. China Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Japan Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. South Korea Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. India Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. Australia Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. China Taiwan Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Indonesia Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Thailand Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Malaysia Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Latin America Rheumatoid Arthritis Medicine Sales Market Share by Country (2018-2029)
    Figure 44. Latin America Rheumatoid Arthritis Medicine Revenue Market Share by Country (2018-2029)
    Figure 45. Mexico Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Brazil Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Argentina Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Middle East & Africa Rheumatoid Arthritis Medicine Sales Market Share by Country (2018-2029)
    Figure 49. Middle East & Africa Rheumatoid Arthritis Medicine Revenue Market Share by Country (2018-2029)
    Figure 50. Turkey Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Saudi Arabia Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 52. UAE Rheumatoid Arthritis Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Global Sales Market Share of Rheumatoid Arthritis Medicine by Type (2018-2029)
    Figure 54. Global Revenue Market Share of Rheumatoid Arthritis Medicine by Type (2018-2029)
    Figure 55. Global Rheumatoid Arthritis Medicine Price (US$/Unit) by Type (2018-2029)
    Figure 56. Global Sales Market Share of Rheumatoid Arthritis Medicine by Application (2018-2029)
    Figure 57. Global Revenue Market Share of Rheumatoid Arthritis Medicine by Application (2018-2029)
    Figure 58. Global Rheumatoid Arthritis Medicine Price (US$/Unit) by Application (2018-2029)
    Figure 59. Rheumatoid Arthritis Medicine Value Chain
    Figure 60. Rheumatoid Arthritis Medicine Production Process
    Figure 61. Channels of Distribution (Direct Vs Distribution)
    Figure 62. Distributors Profiles
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Rheumatoid Arthritis Testing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-33E11182
Mon Feb 05 00:00:00 UTC 2024

Add to Cart

Global Rheumatology Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-29B5986
Mon Feb 05 00:00:00 UTC 2024

Add to Cart

Global Psoriatic Arthritis Therapeutics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-9A6304
Fri Feb 02 00:00:00 UTC 2024

Add to Cart

Global Rheumatic Disorders Drug Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34K5776
Wed Jan 31 00:00:00 UTC 2024

Add to Cart